Format
Items per page
Sort by

Send to:

Choose Destination

Results: 12

Cited In for PubMed (Select 11232643)

1.

Progressive loss of myogenic differentiation in leiomyosarcoma has prognostic value.

Demicco EG, Boland GM, Brewer Savannah KJ, Lusby K, Young ED, Ingram D, Watson KL, Bailey M, Guo X, Hornick JL, van de Rijn M, Wang WL, Torres KE, Lev D, Lazar AJ.

Histopathology. 2015 Apr;66(5):627-38. doi: 10.1111/his.12466. Epub 2015 Jan 12.

PMID:
24889065
2.

Prognostic value of PLAGL1-specific CpG site methylation in soft-tissue sarcomas.

Peille AL, Brouste V, Kauffmann A, Lagarde P, Le Morvan V, Coindre JM, Chibon F, Bresson-Bepoldin L.

PLoS One. 2013 Nov 15;8(11):e80741. doi: 10.1371/journal.pone.0080741. eCollection 2013.

3.

Genomic signatures predict poor outcome in undifferentiated pleomorphic sarcomas and leiomyosarcomas.

Silveira SM, Villacis RA, Marchi FA, Barros Filho Mde C, Drigo SA, Neto CS, Lopes A, da Cunha IW, Rogatto SR.

PLoS One. 2013 Jun 25;8(6):e67643. doi: 10.1371/journal.pone.0067643. Print 2013.

4.

Dual Pten/Tp53 suppression promotes sarcoma progression by activating Notch signaling.

Guijarro MV, Dahiya S, Danielson LS, Segura MF, Vales-Lara FM, Menendez S, Popiolek D, Mittal K, Wei JJ, Zavadil J, Cordon-Cardo C, Pandolfi PP, Hernando E.

Am J Pathol. 2013 Jun;182(6):2015-27. doi: 10.1016/j.ajpath.2013.02.035.

5.

High quality genomic copy number data from archival formalin-fixed paraffin-embedded leiomyosarcoma: optimisation of universal linkage system labelling.

Salawu A, Ul-Hassan A, Hammond D, Fernando M, Reed M, Sisley K.

PLoS One. 2012;7(11):e50415. doi: 10.1371/journal.pone.0050415. Epub 2012 Nov 29.

6.

Constant p53 pathway inactivation in a large series of soft tissue sarcomas with complex genetics.

Pérot G, Chibon F, Montero A, Lagarde P, de Thé H, Terrier P, Guillou L, Ranchère D, Coindre JM, Aurias A.

Am J Pathol. 2010 Oct;177(4):2080-90. doi: 10.2353/ajpath.2010.100104.

7.

Local mesenchymal stem/progenitor cells are a preferential target for initiation of adult soft tissue sarcomas associated with p53 and Rb deficiency.

Choi J, Curtis SJ, Roy DM, Flesken-Nikitin A, Nikitin AY.

Am J Pathol. 2010 Nov;177(5):2645-58. doi: 10.2353/ajpath.2010.100306. Epub 2010 Sep 23.

8.

Integrative genomic characterization and a genomic staging system for gastrointestinal stromal tumors.

Ylipää A, Hunt KK, Yang J, Lazar AJ, Torres KE, Lev DC, Nykter M, Pollock RE, Trent J, Zhang W.

Cancer. 2011 Jan 15;117(2):380-9. doi: 10.1002/cncr.25594. Epub 2010 Sep 3.

9.

Genetic profiling differentiates second primary tumors from metastases in adult metachronous soft tissue sarcoma.

Fernebro J, Carneiro A, Rydholm A, Domanski HA, Karlsson A, Borg A, Nilbert M.

Sarcoma. 2008;2008:431019. doi: 10.1155/2008/431019. Epub 2009 Feb 2.

10.

Genetic aberrations in soft tissue leiomyosarcoma.

Yang J, Du X, Chen K, Ylipää A, Lazar AJ, Trent J, Lev D, Pollock R, Hao X, Hunt K, Zhang W.

Cancer Lett. 2009 Mar 8;275(1):1-8. doi: 10.1016/j.canlet.2008.06.013. Epub 2008 Jul 22. Review.

11.

Expression of smooth muscle markers in so called malignant fibrous histiocytomas.

Hasegawa T, Hasegawa F, Hirose T, Sano T, Matsuno Y.

J Clin Pathol. 2003 Sep;56(9):666-71.

12.

Frequent expression of smooth muscle markers in malignant fibrous histiocytoma of bone.

Ueda T, Araki N, Mano M, Myoui A, Joyama S, Ishiguro S, Yamamura H, Takahashi K, Kudawara I, Yoshikawa H.

J Clin Pathol. 2002 Nov;55(11):853-8.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk